<DOC>
	<DOCNO>NCT02705950</DOCNO>
	<brief_summary>Hypothesis : ITB bolus antinociceptive effect neuropathic pain spinal cord injury patient , could depend subtype pain , lesion level , cervical thoracic spinal cord injury . Objective : To study effect intrathecal baclofen bolus neuropathic pain patient spinal cord injury cervico-dorsal level . Primary Endpoint : Effect intrathecal baclofen bolus neuropathic pain ( measure use Neuropathic Pain Inventory Scale , Brief Pain Inventory Numerical Rating Scale ) spinal cord injury cervico-dorsal level . Secondary Endpoints : 1 . Spasticity spasm ( measure use Modified Ashworth Scale Visual Analogue Scale Penn Spasm Frequency Scale ) . 2 . Neurophysiological examination ( warm perception threshold , heat pain perception threshold , evoke pain perception contact heat evoke potential ) .</brief_summary>
	<brief_title>Intrathecal Baclofen ( ITB ) Bolus Neuropathic Pain ( NP ) . Preliminary Study .</brief_title>
	<detailed_description>The study randomize , double-blind ( patient realize clinical neurophysiologic evaluation ) , placebo-controlled trial . We recruit 10-12 patient SCI complete incomplete lesion cervical thoracic level randomly distribute two study group : ITB bolus group placebo group . In 6-8 month , administer intrathecal baclofen bolus 50 µg ( 1ml ) 5-6 SCI patient 1ml physiologic serum subcutaneously 5-6 SCI patient . Before intrathecal baclofen placebo bolus administer , patient evaluate neuropathic pain , use Neuropathic Pain Inventory Scale , Brief Pain Inventory Numerical Rating Scale . Spasticity spasm also measure Modified Ashworth Scale , Visual Analogue Scale Penn Spasm . After , patient also undergo , early morning intrathecal baclofen placebo bolus administer , neurophysiology assessment ( warm perception threshold , heat pain perception threshold , evoke pain perception contact heat evoke potential ) . After neurophysiological evaluation , patient receive intrathecal baclofen bolus 50 µg placebo ( randomization ) . After intrathecal baclofen placebo injection , clinical neurophysiological examination , neuropathic pain spasticity spasm , repeat 1 , 2 4 hour bolus administration . Moreover , Kumru et al . ( 2013 ) report 50 µg intrathecal baclofen bolus reduce pain perception threshold evoke acute pain perception patient SCI . During evaluation period , patient continue analgesic , antispastic and/or stable medication .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>Age 1870 year least one year since spinal cord injury . Aetiology : stable SCI traumatic medical origin . Patients chronic refractory neuropathic pain spinal cord injury , complete incomplete , cervicothoracic level . Severity pain equal great 4 Numerical Rating Scale . With spasticity ( MAS &gt; = ) . Stable analgesic , antispastic medication . Patients give patient inform consent . Contraindication baclofen intrathecal injection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>